Form Bio Blog

Updates and perspectives from our industry experts, scientists and product leaders.

Category
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
 De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings
Featured
Cell and Gene Therapy

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

Claire Aldridge, PhD

Claire Aldridge, PhD

Our Chief Strategy Officer, Claire Aldridge, PhD, explores the growing trend of early integration of biomanufacturing design to cut costs and time-to-market while improving patient access to gene therapy.

Leveraging AI Models To Improve Safety of Gene Therapy
Featured
Cell and Gene Therapy

Leveraging AI Models To Improve Safety of Gene Therapy

Nick Ketz, PhD

Nick Ketz, PhD

Learn how predictive modeling can generate synthetic regulatory sequences for safer and more efficacious gene therapies.

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing
Featured
Cell and Gene Therapy

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing

Andrew Busey & Kent Wakeford

Andrew Busey & Kent Wakeford

We support the commitment of the Biden-Harris Administration to address global issues through biomanufacturing innovation. Learn more.

Shortening Gene Therapy Development Time with Strategic Use of Large Language Models
Featured
Cell and Gene Therapy

Shortening Gene Therapy Development Time with Strategic Use of Large Language Models

Austin Day, PhD

Austin Day, PhD

Leveraging large language models has proven to shorten the development time of gene therapies. Learn more here.

New Study Finds Large Language Models Applied to DNA Sequences Enabled Accurate Molecular Phenotype Prediction
Featured
Computational Life Sciences

New Study Finds Large Language Models Applied to DNA Sequences Enabled Accurate Molecular Phenotype Prediction

Austin Day, PhD

Austin Day, PhD

Recent published research is bringing us one step closer to predicting molecular phenotypes from a DNA sequence. Read this blog to learn more.

Maximizing Therapeutic Efficacy Through Codon Substitution Design
Featured
Computational Life Sciences

Maximizing Therapeutic Efficacy Through Codon Substitution Design

Sasha Maslova

Sasha Maslova

Get insights from Sasha, our Artificial Intelligence (AI) Scientist, on a newly published article describing the potential undesirable effects of synonymous codon substitution and the role of computational methods to overcome these challenges.

The Power of Integrating Single-Cell Multi-Omic Analysis to Accelerate Cell and Gene Therapy Biomanufacturing
Featured
Cell and Gene Therapy

The Power of Integrating Single-Cell Multi-Omic Analysis to Accelerate Cell and Gene Therapy Biomanufacturing

Jill Roughan, PhD

Jill Roughan, PhD

Single-cell analysis techniques and multi-omics are providing a newfound understanding of hidden complexity in biological systems, revolutionizing the biomanufacturing process for cell and gene therapies. Here’s how.

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers
Featured
Cell and Gene Therapy

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers

Austin Day, PhD

Austin Day, PhD

Continuing our blog series on Transformer architectures and their use in gene therapy applications, we explore the latest variants’ size and speed improvements.

Applying DeepMind's Transformer Architecture to Optimize AAV Constructs
Featured
Cell and Gene Therapy

Applying DeepMind's Transformer Architecture to Optimize AAV Constructs

Nick Ketz, PhD

Nick Ketz, PhD

Transformer based architectures are uniquely efficient and powerful when used to process structured data. Read this blog to learn how they can be customized, adapted and applied to AAV construct optimization.

What’s Next for Viral Vectors Within Gene Therapy Clinical Trials
Featured
Cell and Gene Therapy

What’s Next for Viral Vectors Within Gene Therapy Clinical Trials

Jill Roughan, PhD

Jill Roughan, PhD

In this article, we take a look at the role of viral vectors in gene therapy clinical trials, including current challenges and leveraging artificial intelligence to advance the field.

7 Powerful Ways to Visualize RNA-Seq Data for Gene Therapy Development
Featured
Computational Life Sciences

7 Powerful Ways to Visualize RNA-Seq Data for Gene Therapy Development

Jill Roughan, PhD

Jill Roughan, PhD

Want to know more about the foundational types and common tools to use for RNA-Seq data visualization in gene therapy development? Read this blog to find out.

How Next-Generation Editing Technologies are Transforming Cell and Gene Therapies
Featured
Computational Life Sciences

How Next-Generation Editing Technologies are Transforming Cell and Gene Therapies

Jill Roughan, PhD

Jill Roughan, PhD

Since their discovery, CRISPR-Cas systems have changed and evolved. Read about how base, prime, and RNA editing are driving new therapeutic applications.

Form Bio Resources

Board of Directors

Doe

Johnnn

Doe

,

Ph.D.

CEO
Doe

Johnn

Doe

,

Ph.D.

CEO
Doe

John

Doe

,

Ph.D.

CEO
Doe

Johnnn

Doe

,

Ph.D.

CEO

Form Bio Resources